Our top takeaways from the health and medicine edition of the world-famous TED conference.

Plus, how the field of diabetes can learn from the environmental movement.

The best way in which our access to data should change is up for debate.

Behavioral expert Dr. Bill Polonsky on how providers and caregivers can reframe diabetes conversations.

Plus, what we learned about Companion Medical’s smart insulin pen.

Incredible presentation from CEO Derek Rapp on the state of the foundation. Plus, updates on the Bionic Pancreas and ViaCyte!

less risk of diabetes complications, lower A1c, improved weight loss and hypoglycemia; led by Novo Nordisk’s Victoza and semaglutide

Our own Kelly Close moderates a panel at SXSW Interactive.

Glucose, food, exercise, and even DIY closed loop on the phone

“We have to create solutions in diabetes that are as addictive as the iPhone.”

Views on FDA regulation, pipeline updates, and first vs. next-generation systems.

LEADER results announced at #2016ADA – compared to placebo, Victoza reduces risk of cardiovascular death by 22%, plus a 22% reduction in kidney disease. More results...

A standing ovation for Dr. Margaret Powers at ADA last month r Dr. Margaret Powers at ADA last month.

The Annual TCOYD/The diaTribe Foundation Forum Celebrates its 10 th Anniversary in New Orleans

Saturday, August 27; $10 early bird registration fee

ADA statement of support released at the 2 nd Diabetes Surgery Summit; highlights reversal of diabetes symptoms after surgery for some candidates

Advice for increasing daily activity, the new Fit2Me mobile app, and enthusiasm for the National Diabetes Prevention Program

The diaTribe Foundation’s 2016 gathering shares need for earlier treatment, data integration, prevention, amplifying patient voices, and reducing stigma.

Research reveals improved A1c and weight loss benefits for people with type 1 diabetes on sotagliflozin, but a slightly increased risk of DKA

Hosted by TCOYD in San Diego, CA from June 23-25; early-bird registration until March 23